-
Highest British business award goes to cannabis drug developer, GW Pharmaceuticals
europeanpharmaceuticalreview
April 30, 2021
The Queen’s Award for Enterprise in Innovation was awarded to GW for leadership in cannabinoid science and development of prescription cannabis-based medicines.
-
Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio
expresspharma
February 04, 2021
The deal will allow Jazz to move beyond sleep disorders and cancer treatments by beefing up its neuroscience unit.
-
FDA Encourages Use of Drug Master Files to Support Cannabis Research
americanpharmaceuticalreview
September 27, 2020
The U.S. Food and Drug Administration (FDA) is alerting those involved in research on drugs containing cannabis and cannabis-derived compounds of the potential benefits of using Drug Master Files (DMFs).
-
Cannformatics Receives Pilot Study Approval Identifying Cannabis-Responsive Biomarkers in Autism
americanpharmaceuticalreview
August 21, 2020
Cannformatics has received Institutional Review Board (IRB) approval to conduct a pilot study to identify cannabisresponsive biomarkers in children with autism spectrum disorder.
-
Report calls for development of new cannabis testing technologies
europeanpharmaceuticalreview
July 15, 2020
According to research, the rise in demand for high-quality cannabis will also drive growth in the cannabis testing market, where new technologies are needed to overcome current limitations.
-
Handheld Raman spectrometer developed to analyse THC levels in cannabis plants
europeanpharmaceuticalreview
March 19, 2020
Researchers have modified a portable Raman spectrometer that can determine the level of THC in cannabis plants, which they say could be used by farmers wishing to grow hemp.
-
Import restrictions for cannabis-based medicines in UK updated
europeanpharmaceuticalreview
March 04, 2020
The UK government has changed the restrictions on importing cannabis-based medicine products into the country, allowing wholesalers to bring in larger quantities.
-
Marijuana Use for MS Tied to Legal Permissiveness
drugs
December 30, 2019
Cannabis use among patients with multiple sclerosis (MS) is more likely where cannabis laws are more permissive, according to a study published in the February issue of Multiple Sclerosis and Related Disorders.
-
Regular Cannabis Use May Cause Adverse Cardiac Changes
drugs
December 27, 2019
Regular recreational cannabis use is associated with alterations in cardiac structure and function, according to a letter to the editor published in the December issue of JACC: Cardiovascular Imaging.
-
Cannabis Use Disorder May Up Risk of Perioperative Heart Attack
drugs
December 19, 2019
Active cannabis use disorder is associated with an increased perioperative risk of myocardial infarction, according to a study published in the December issue of Anesthesiology.